Abcuro to Present Two Posters at the American Academy of Neurology 2025 Annual Meeting

Abcuro to Present Two Posters at the American Academy of Neurology 2025 Annual Meeting

NEWTON, Mass.–(BUSINESS WIRE)–Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells,…

Article Source
https://www.biospace.com/press-releases/abcuro-to-present-two-posters-at-the-american-academy-of-neurology-2025-annual-meeting